VOLTAREN Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Voltaren, and what generic alternatives are available?

Voltaren is a drug marketed by Novartis and Haleon Us Holdings and is included in four NDAs.

The generic ingredient in VOLTAREN is diclofenac sodium. There are forty-seven drug master file entries for this compound. One hundred and twenty-eight suppliers are listed for this compound. Additional details are available on the diclofenac sodium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Voltaren

A generic version of VOLTAREN was approved as diclofenac sodium by ACTAVIS ELIZABETH on March 26^th, 1996.

Sign Up

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for VOLTAREN?
What are the global sales for VOLTAREN?
What is Average Wholesale Price for VOLTAREN?

Summary for VOLTAREN

US Patents:	0
Applicants:	2
NDAs:	4
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	121
Clinical Trials:	56
Patent Applications:	4,203
Drug Prices:	Drug price information for VOLTAREN
Drug Sales Revenues:	Drug sales revenues for VOLTAREN
What excipients (inactive ingredients) are in VOLTAREN?	VOLTAREN excipients list
DailyMed Link:	VOLTAREN at DailyMed

Drug patent expirations by year for VOLTAREN

Recent Clinical Trials for VOLTAREN

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Washington State University	Early Phase 1
University of Rijeka	N/A
German University in Cairo	Phase 2

See all VOLTAREN clinical trials

Pharmacology for VOLTAREN

Drug Class	Anti-coagulant Calculi Dissolution Agent
Mechanism of Action	Acidifying Activity Calcium Chelating Activity
Physiological Effect	Decreased Coagulation Factor Activity

US Patents and Regulatory Information for VOLTAREN

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Novartis	VOLTAREN	diclofenac sodium	SOLUTION/DROPS;OPHTHALMIC	020037-001	Mar 28, 1991		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-003	Jul 28, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-001	Jul 28, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-002	Jul 28, 1988		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Novartis	VOLTAREN-XR	diclofenac sodium	TABLET, EXTENDED RELEASE;ORAL	020254-001	Mar 8, 1996		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Haleon Us Holdings	VOLTAREN ARTHRITIS PAIN	diclofenac sodium	GEL;TOPICAL	022122-001	Oct 17, 2007		OTC	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for VOLTAREN

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-001	Jul 28, 1988	⤷ Sign Up	⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	SOLUTION/DROPS;OPHTHALMIC	020037-001	Mar 28, 1991	⤷ Sign Up	⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	SOLUTION/DROPS;OPHTHALMIC	020037-001	Mar 28, 1991	⤷ Sign Up	⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-003	Jul 28, 1988	⤷ Sign Up	⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	SOLUTION/DROPS;OPHTHALMIC	020037-001	Mar 28, 1991	⤷ Sign Up	⤷ Sign Up
Novartis	VOLTAREN	diclofenac sodium	TABLET, DELAYED RELEASE;ORAL	019201-002	Jul 28, 1988	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for VOLTAREN

See the table below for patents covering VOLTAREN around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Hong Kong	1394	PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION IN THE EYE	⤷ Sign Up
Japan	S62242617	OPHTHALMIC REMEDY	⤷ Sign Up
Singapore	13194		⤷ Sign Up
Spain	2038691		⤷ Sign Up
Greece	3002659		⤷ Sign Up
European Patent Office	0242328	PHARMACEUTICAL COMPOSITION FOR TREATING INFLAMMATION IN THE EYE	⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

AI Research Assistant

Questions you can ask:

Summary for VOLTAREN

Recent Clinical Trials for VOLTAREN

Pharmacology for VOLTAREN

Make Better Decisions: Try a trial or see plans & pricing